Vickie L. Capps - 11 Mar 2025 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ J. Andres Cedron, attorney-in-fact
Issuer symbol
OFIX
Transactions as of
11 Mar 2025
Net transactions value
$0
Form type
4
Filing time
13 Mar 2025, 16:21:57 UTC
Previous filing
07 Nov 2024
Next filing
06 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +3,093 $0.000000 3,093 11 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OFIX Employee Stock Option (Right to Buy) Award $0 +35,270 $0.000000 35,270 11 Mar 2025 Common Stock 35,270 $17.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2025 or (ii) the date on which the issuer holds its 2025 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
F2 The options vest and become exercisable with respect to 25% of the shares covered thereby on the first, second, third and fourth anniversary of the Grant Date.